Pinaverium

ELDICET 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

50 mg comprimido recubierto con películaSpainMarketedAuthorised 30 Nov 1980

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Pinaverium

ELDICET 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

50 mg comprimido recubierto con películaSpainMarketedAuthorised 30 Nov 1980

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

DicetelTaiwan · 膠囊劑 · 臺順貿易股份有限公司

Packs

Pack	Code	Status
ELDICET 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 50 comprimidos	955583

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Pinaverium
Strength: 50 mg
Dosage form: comprimido recubierto con película
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 30 Nov 1980
Registration: 55339
Marketing authorisation holder: Viatris Healthcare Limited
Procedure: National, MRP or DCP
Supply: Medicamento Sujeto A Prescripción Médica